The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: A sub-study of the VISION trial.
 
Jens Kurth
No Relationships to Disclose
 
Ken Herrmann
Stock and Other Ownership Interests - iTheranostics; SOFIE
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Bayer; BTG; Curium Pharma; Ipsen; Sirtex Medical
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Ipsen
Speakers' Bureau - Advanced Accelerator Applications/Novartis; Amgen; Bayer; BTG; Curium Pharma; Ipsen; Sirtex Medical
Research Funding - BTG
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis; Amgen; Bayer; BTG; Curium Pharma; Ipsen; Sirtex Medical
 
Matthias Eiber
Consulting or Advisory Role - ABX Advanced biochemical compounds; Blue Earth Diagnostics
Research Funding - ABX Advanced biochemical compounds; Blue Earth Diagnostics; Siemens
Patents, Royalties, Other Intellectual Property - patent application for rhPSMA
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Kambiz Rahbar
Honoraria - Advanced Accelerator Applications/Novartis; Advanced Biochemical Compounds; Amgen; Sirtex Medical
Consulting or Advisory Role - Advanced Biochemical Compounds; Bayer
 
Martin Heuschkel
Stock and Other Ownership Interests - Biogen
Travel, Accommodations, Expenses - Novartis
 
Michael Lassmann
Research Funding - ABX advanced biochemical compounds (Inst); Ipsen (Inst); Nordic Nanovector (Inst)
 
Walter Jentzen
Research Funding - Siemens Healthineers
 
Daniela Chicco
Employment - Advanced Accelerator Applications/Novartis
Patents, Royalties, Other Intellectual Property - Advanced Accelerator Applications/Novartis (Inst)
 
Richard Messmann
Employment - Endocyte
 
A. Oliver Sartor
Stock and Other Ownership Interests - Abbvie; Cardinal Health; GlaxoSmithKline; Lilly; United Health Group; Varian Medical Systems
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bavarian Nordic; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Constellation Pharmaceuticals; Dendreon; EMD Serono; Endocyte; Johnson & Johnson; Myovant Sciences; Myriad Genetics; Novartis; Noxopharm; Pfizer; Progenics; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Endocyte (Inst); Innocrin Pharma (Inst); InVitae (Inst); Johnson & Johnson (Inst); Merck (Inst); Sanofi (Inst)
Expert Testimony - Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Johnson & Johnson; Progenics; Sanofi
 
Michael J. Morris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Blue Earth Diagnostics; Endocyte; ORIC Pharmaceuticals; Tokai Pharmaceuticals; Tolmar
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Endocyte
 
Bernd J. Krause
No Relationships to Disclose